CareDx

ISIN US14167L1035

 | 

WKN A118WG

Market cap (in EUR)
855 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
Show more Show less
Healthcare Healthcare Equipment United States

Financials

Key metrics

Market capitalisation, EUR 855 m
EPS, EUR 1.08
P/B ratio 3.2
P/E ratio 16.3
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 309 m
Net income, EUR 49 m
Profit margin 15.74%

What ETF is CareDx in?

There are 3 ETFs which contain CareDx. All of these ETFs are listed in the table below. The ETF with the largest weighting of CareDx is the L&G Healthcare Technology & Innovation UCITS ETF USD Acc.
ETF Weight Investment focus Fund size (in m EUR)
L&G Russell 2000 US Small Cap Quality UCITS ETF 0.05%
Equity
United States
Small Cap
172
L&G Healthcare Technology & Innovation UCITS ETF USD Acc 1.60%
Equity
World
Health Care
Innovation
152
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.01%
Equity
United States
Small Cap
176
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.